Partnership for Part D Access
  • Home
  • About Us
    • Who We Are
    • Patient Communities
    • Our Leadership
  • The Issue
    • Six Protected Classes
    • History
  • Resources
  • Newsroom
  • Stakeholder Voices
  • Contact Us
  • Home
  • About Us
    • Who We Are
    • Patient Communities
    • Our Leadership
  • The Issue
    • Six Protected Classes
    • History
  • Resources
  • Newsroom
  • Stakeholder Voices
  • Contact Us

Newsroom​ 

Washington Examiner: Outside Groups Prepare to Fight Trump Drug Pricing Proposal

1/31/2019

0 Comments

 
Picture
This post originally appeared in the Washington Examiner on January 31, 2019. .

Outside groups prepare to fight Trump drug pricing proposal. Outside groups involved with fighting HIV, epilepsy, and serious mental illness are prepared to battle the Trump administration on a plan to change Medicare Part D, the portion of the program that covers prescription drugs. The administration has proposed making changes to what are known as the “six protected classes” of drugs, which allow certain patients with serious health conditions to receive any drug that their doctor determines is best to treat them. ​

Under the administration’s plan, aimed at reducing drug spending, insurance companies would be able to require that doctors try certain less expensive drugs first, or require doctors to check with an insurance company before they issue a prescription. The organizations, which receive some funding from drug companies, said such a move would harm patients, even risking their lives, because insurance companies could even discontinue a medication that patients are already finding effective. The organizations, which have banded together to form the Partnership for Part D Access, are lobbying members of Congress to have them undo the proposal if it should become a final rule. If that doesn’t work, they signalled in a meeting with reporters Wednesday that they were prepared to sue.

​“Patients and their families should not be paws in this fight,” said Andrew Sperling, director of legislative and policy advocacy at the National Alliance on Mental Illness. “We are going to continue to push back on the Trump administration on this.” Medicare patients who require the medicines are not only 65 and older, but many of them are younger and qualify for Medicare because their health condition meets the program’s provisions for people with disabilities. The Trump administration finished collecting comments on the proposal Jan. 25.
0 Comments



Leave a Reply.

    Author

    Write something about yourself. No need to be fancy, just an overview.

    Archives

    September 2022
    November 2021
    March 2021
    February 2021
    January 2021
    November 2020
    January 2020
    July 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    April 2018
    March 2018
    September 2017
    May 2017
    April 2017
    November 2016
    July 2016

    Categories

    All

    RSS Feed

Learn more

About Us
Patient Communities
​Issues
​Background

What's New?

​Newsroom
Resources
​

Contact

Contact Us
E-Mail 
© COPYRIGHT 2018. ALL RIGHTS RESERVED.